Spectinomycin

DB00919ApprovedVet approvedWithdrawnSmall molecule

Spectinomycin is an aminocyclitol antibiotic used to treat susceptible strains of Neisseria gonorrhoeae. An antibiotic produced by Streptomyces spectabilis.

Chemical structure of Spectinomycin
Mechanism
Curator reviewed
Primary indication
For use in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of Neisseria gonorrhoeae.Curator reviewed
Formula / weight
C14H24N2O7 · 332.3496 g/mol (avg)
First approval
Canada, 1972 · United States, 1971
Code names
Antibiotic 2233wp · CHX-3101

Resolves to

Compound
UNII93AKI1U6QFCAS1695-77-8ChEMBLCHEMBL1167ChEBI9215PubChem15541KEGGC02078
Clinical / RWD
RxNorm270ATCJ01XX04PharmGKBPA164781342
Structure
InChIKeyUNFWWIHTNXNPBV-WXKVUWSESA-NSMILES[H][C@@]12O[C@H](C)CC(=O)[C@]1(O)O[C@]1([H])[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@@]1([H])O2
Targets
P0A7S3rpsL

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
60Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5Marketed productsAcross 4 countries and 5 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Spectinomycin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In